by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 120 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 46, no: 8 |
NetGPI | no | yes: 0, no: 54 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 55 |
GO:0016020 | membrane | 2 | 14 |
GO:0042995 | cell projection | 2 | 55 |
GO:0043226 | organelle | 2 | 55 |
GO:0043227 | membrane-bounded organelle | 3 | 55 |
GO:0110165 | cellular anatomical entity | 1 | 55 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 55 |
GO:0005886 | plasma membrane | 3 | 3 |
Related structures:
AlphaFold database: Q4QGJ7
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004672 | protein kinase activity | 3 | 1 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 1 |
GO:0016301 | kinase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.698 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.698 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.706 |
DEG_SCF_FBW7_1 | 272 | 278 | PF00400 | 0.467 |
DEG_SCF_FBW7_2 | 303 | 308 | PF00400 | 0.470 |
DEG_SPOP_SBC_1 | 275 | 279 | PF00917 | 0.476 |
DEG_SPOP_SBC_1 | 281 | 285 | PF00917 | 0.476 |
DOC_CKS1_1 | 272 | 277 | PF01111 | 0.468 |
DOC_CYCLIN_RxL_1 | 105 | 116 | PF00134 | 0.307 |
DOC_CYCLIN_RxL_1 | 182 | 193 | PF00134 | 0.302 |
DOC_CYCLIN_RxL_1 | 3 | 13 | PF00134 | 0.514 |
DOC_MAPK_MEF2A_6 | 229 | 236 | PF00069 | 0.382 |
DOC_PP1_RVXF_1 | 108 | 115 | PF00149 | 0.313 |
DOC_USP7_MATH_1 | 209 | 213 | PF00917 | 0.323 |
DOC_USP7_MATH_1 | 351 | 355 | PF00917 | 0.387 |
DOC_USP7_MATH_2 | 151 | 157 | PF00917 | 0.303 |
DOC_USP7_UBL2_3 | 340 | 344 | PF12436 | 0.325 |
DOC_USP7_UBL2_3 | 59 | 63 | PF12436 | 0.322 |
DOC_WW_Pin1_4 | 262 | 267 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 271 | 276 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 295 | 300 | PF00397 | 0.656 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.479 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.315 |
LIG_14-3-3_CanoR_1 | 276 | 281 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 43 | 48 | PF00244 | 0.353 |
LIG_Actin_WH2_2 | 153 | 168 | PF00022 | 0.297 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.625 |
LIG_deltaCOP1_diTrp_1 | 62 | 69 | PF00928 | 0.356 |
LIG_EVH1_1 | 271 | 275 | PF00568 | 0.466 |
LIG_FHA_1 | 263 | 269 | PF00498 | 0.569 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.456 |
LIG_FHA_1 | 42 | 48 | PF00498 | 0.380 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.336 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.505 |
LIG_FHA_2 | 283 | 289 | PF00498 | 0.491 |
LIG_FHA_2 | 307 | 313 | PF00498 | 0.411 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.437 |
LIG_LIR_Gen_1 | 113 | 121 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 128 | 135 | PF02991 | 0.365 |
LIG_LIR_Gen_1 | 200 | 209 | PF02991 | 0.415 |
LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 200 | 205 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.403 |
LIG_PDZ_Class_2 | 370 | 375 | PF00595 | 0.295 |
LIG_SH2_STAT5 | 334 | 337 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.342 |
LIG_SH3_3 | 269 | 275 | PF00018 | 0.467 |
LIG_SH3_3 | 287 | 293 | PF00018 | 0.482 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.408 |
LIG_Sin3_3 | 359 | 366 | PF02671 | 0.266 |
LIG_SUMO_SIM_anti_2 | 158 | 164 | PF11976 | 0.316 |
LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 232 | 238 | PF11976 | 0.345 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.376 |
MOD_CDK_SPK_2 | 271 | 276 | PF00069 | 0.467 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.393 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.351 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.533 |
MOD_CK1_1 | 197 | 203 | PF00069 | 0.336 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.466 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.353 |
MOD_CK2_1 | 130 | 136 | PF00069 | 0.346 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.472 |
MOD_CK2_1 | 282 | 288 | PF00069 | 0.474 |
MOD_CK2_1 | 306 | 312 | PF00069 | 0.439 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.446 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.643 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.581 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.571 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.694 |
MOD_GlcNHglycan | 193 | 197 | PF01048 | 0.576 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.574 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.661 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.733 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.558 |
MOD_GlcNHglycan | 354 | 357 | PF01048 | 0.292 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.560 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.423 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.470 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.486 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.420 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.388 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.531 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.559 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.477 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.574 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.498 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.509 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.506 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.340 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.731 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.674 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.412 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.324 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.507 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.403 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.577 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.556 |
MOD_NEK2_2 | 209 | 214 | PF00069 | 0.290 |
MOD_PK_1 | 142 | 148 | PF00069 | 0.315 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.312 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.491 |
MOD_Plk_1 | 338 | 344 | PF00069 | 0.360 |
MOD_Plk_2-3 | 136 | 142 | PF00069 | 0.345 |
MOD_Plk_2-3 | 68 | 74 | PF00069 | 0.323 |
MOD_Plk_4 | 158 | 164 | PF00069 | 0.368 |
MOD_ProDKin_1 | 262 | 268 | PF00069 | 0.490 |
MOD_ProDKin_1 | 271 | 277 | PF00069 | 0.550 |
MOD_ProDKin_1 | 295 | 301 | PF00069 | 0.654 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.311 |
MOD_SUMO_rev_2 | 224 | 230 | PF00179 | 0.333 |
MOD_SUMO_rev_2 | 332 | 341 | PF00179 | 0.339 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.405 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 185 | 190 | PF00026 | 0.503 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZ17 | Leptomonas seymouri | 31% | 100% |
A0A0S4JEJ4 | Bodo saltans | 25% | 100% |
A0A3Q8I9A6 | Leishmania donovani | 55% | 97% |
A0A3Q8I9D0 | Leishmania donovani | 56% | 100% |
A0A3Q8IC27 | Leishmania donovani | 31% | 79% |
A0A3Q8IIJ9 | Leishmania donovani | 31% | 100% |
A0A3S5H6D6 | Leishmania donovani | 32% | 100% |
A0A3S7WP69 | Leishmania donovani | 21% | 100% |
A0A3S7WPB2 | Leishmania donovani | 30% | 100% |
A0A3S7X4J4 | Leishmania donovani | 31% | 100% |
A4H4D2 | Leishmania braziliensis | 24% | 100% |
A4H4G6 | Leishmania braziliensis | 29% | 100% |
A4H5P0 | Leishmania braziliensis | 28% | 100% |
A4HBX3 | Leishmania braziliensis | 31% | 83% |
A4HJC8 | Leishmania braziliensis | 30% | 100% |
A4HSL2 | Leishmania infantum | 21% | 100% |
A4HTX9 | Leishmania infantum | 32% | 100% |
A4HVB0 | Leishmania infantum | 51% | 93% |
A4HZ93 | Leishmania infantum | 31% | 79% |
A4I6S4 | Leishmania infantum | 31% | 100% |
D1GJ51 | Leishmania infantum | 50% | 81% |
E8NHG5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 84% |
E8NHP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9ACQ0 | Leishmania major | 30% | 100% |
E9AG65 | Leishmania infantum | 30% | 100% |
E9AGG5 | Leishmania infantum | 57% | 90% |
E9AGG9 | Leishmania infantum | 56% | 69% |
E9AGH0 | Leishmania infantum | 56% | 99% |
E9AKJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 22% | 100% |
E9AKM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AMQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AP02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 57% | 100% |
E9AP03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 96% |
E9AP05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 49% | 73% |
E9AP07 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 58% | 100% |
E9AP08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 56% | 89% |
E9B1U4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B1U5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 89% |
E9B1U6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
P21978 | Leishmania amazonensis | 53% | 79% |
Q25331 | Leishmania major | 94% | 100% |
Q4Q6B6 | Leishmania major | 29% | 100% |
Q4Q6B7 | Leishmania major | 29% | 100% |
Q4QC79 | Leishmania major | 29% | 82% |
Q4QGI0 | Leishmania major | 60% | 74% |
Q4QGI2 | Leishmania major | 46% | 67% |
Q4QGI4 | Leishmania major | 47% | 70% |
Q4QGI6 | Leishmania major | 71% | 69% |
Q4QGJ4 | Leishmania major | 94% | 100% |
Q4QGK2 | Leishmania major | 52% | 67% |
Q4QGK6 | Leishmania major | 94% | 97% |
Q4QGL4 | Leishmania major | 63% | 95% |
Q4QHW6 | Leishmania major | 33% | 100% |
Q4QJB2 | Leishmania major | 21% | 100% |